Vertex Pharmaceuticals Incorporated

NASDAQ:VRTX

504.77 (USD) • At close March 14, 2025
Bedrijfsnaam Vertex Pharmaceuticals Incorporated
Symbool VRTX
Munteenheid USD
Prijs 504.77
Beurswaarde 129,619,888,300
Dividendpercentage 0%
52-weken bereik 377.85 - 519.88
Industrie Biotechnology
Sector Healthcare
CEO Dr. Reshma Kewalramani FASN, M.D.
Website https://www.vrtx.com

Over Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF

Vergelijkbare Aandelen

Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGN

666.87 USD

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

484.44 USD

Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILD

111.44 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

34.62 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

85.6 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.23 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Biogen Inc. logo

Biogen Inc.

BIIB

139.44 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)